ID   4F2_RAT                 Reviewed;         527 AA.
AC   Q794F9;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   24-JUL-2024, entry version 147.
DE   RecName: Full=Amino acid transporter heavy chain SLC3A2 {ECO:0000305};
DE   AltName: Full=4F2 cell-surface antigen heavy chain {ECO:0000250|UniProtKB:P08195};
DE            Short=4F2hc {ECO:0000250|UniProtKB:P08195};
DE   AltName: Full=Solute carrier family 3 member 2 {ECO:0000250|UniProtKB:P08195};
DE   AltName: CD_antigen=CD98;
GN   Name=Slc3a2 {ECO:0000312|RGD:3073};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000269|PubMed:9480885, ECO:0000312|EMBL:AAC53560.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RC   STRAIN=Sprague-Dawley {ECO:0000312|EMBL:AAC53560.1};
RC   TISSUE=Jejunal epithelium {ECO:0000312|EMBL:AAC53560.1};
RX   PubMed=9480885; DOI=10.1042/bj3300745;
RA   Yao S.Y.M., Muzyka W.R., Elliott J.F., Cheeseman C.I., Young J.D.;
RT   "Cloning and functional expression of a cDNA from rat jejunal epithelium
RT   encoding a protein (4F2hc) with system y+L amino acid transport activity.";
RL   Biochem. J. 330:745-752(1998).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAA33036.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBUNIT.
RC   TISSUE=Glial tumor {ECO:0000269|PubMed:9726963};
RX   PubMed=9726963; DOI=10.1074/jbc.273.37.23629;
RA   Kanai Y., Segawa H., Miyamoto K., Uchino H., Takeda E., Endou H.;
RT   "Expression cloning and characterization of a transporter for large neutral
RT   amino acids activated by the heavy chain of 4F2 antigen (CD98).";
RL   J. Biol. Chem. 273:23629-23632(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND SUBUNIT.
RC   TISSUE=Placenta;
RX   PubMed=10049700; DOI=10.1006/bbrc.1999.0206;
RA   Prasad P.D., Wang H., Huang W., Kekuda R., Rajan D.P., Leibach F.H.,
RA   Ganapathy V.;
RT   "Human LAT1, a subunit of system L amino acid transporter: molecular
RT   cloning and transport function.";
RL   Biochem. Biophys. Res. Commun. 255:283-288(1999).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=10391916; DOI=10.1074/jbc.274.28.19745;
RA   Segawa H., Fukasawa Y., Miyamoto K., Takeda E., Endou H., Kanai Y.;
RT   "Identification and functional characterization of a Na+-independent
RT   neutral amino acid transporter with broad substrate selectivity.";
RL   J. Biol. Chem. 274:19745-19751(1999).
RN   [6]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11095508; DOI=10.1097/00001756-200011090-00021;
RA   Matsuo H., Tsukada S., Nakata T., Chairoungdua A., Kim D.K., Cha S.H.,
RA   Inatomi J., Yorifuji H., Fukuda J., Endou H., Kanai Y.;
RT   "Expression of a system L neutral amino acid transporter at the blood-brain
RT   barrier.";
RL   NeuroReport 11:3507-3511(2000).
RN   [7]
RP   FUNCTION.
RX   PubMed=12614332; DOI=10.1046/j.1471-4159.2003.01622.x;
RA   Boado R.J., Li J.Y., Pardridge W.M.;
RT   "Site-directed mutagenesis of rabbit LAT1 at amino acids 219 and 234.";
RL   J. Neurochem. 84:1322-1331(2003).
RN   [8]
RP   INDUCTION.
RX   PubMed=15120633; DOI=10.1016/j.bbrc.2004.04.062;
RA   Padbury J.F., Diah S.K., McGonnigal B., Miller C., Fugere C., Kuzniar M.,
RA   Thompson N.L.;
RT   "Transcriptional regulation of the LAT-1/CD98 light chain.";
RL   Biochem. Biophys. Res. Commun. 318:529-534(2004).
RN   [9]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15980244; DOI=10.1167/iovs.04-1175;
RA   Tomi M., Mori M., Tachikawa M., Katayama K., Terasaki T., Hosoya K.;
RT   "L-type amino acid transporter 1-mediated L-leucine transport at the inner
RT   blood-retinal barrier.";
RL   Invest. Ophthalmol. Vis. Sci. 46:2522-2530(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND THR-5, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [11]
RP   FUNCTION.
RX   PubMed=23426681; DOI=10.1523/jneurosci.3836-12.2013;
RA   Rosenberg D., Artoul S., Segal A.C., Kolodney G., Radzishevsky I.,
RA   Dikopoltsev E., Foltyn V.N., Inoue R., Mori H., Billard J.M., Wolosker H.;
RT   "Neuronal D-serine and glycine release via the Asc-1 transporter regulates
RT   NMDA receptor-dependent synaptic activity.";
RL   J. Neurosci. 33:3533-3544(2013).
CC   -!- FUNCTION: Acts as a chaperone that facilitates biogenesis and
CC       trafficking of functional transporters heterodimers to the plasma
CC       membrane. Forms heterodimer with SLC7 family transporters (SLC7A5,
CC       SLC7A6, SLC7A7, SLC7A8, SLC7A10 and SLC7A11), a group of amino-acid
CC       antiporters (PubMed:10049700, PubMed:10391916, PubMed:12614332,
CC       PubMed:15980244, PubMed:23426681, PubMed:9480885, PubMed:9726963).
CC       Heterodimers function as amino acids exchangers, the specificity of the
CC       substrate depending on the SLC7A subunit (By similarity). Heterodimers
CC       formed by SLC3A2/SLC7A6 or SLC3A2/SLC7A7 mediate the uptake of dibasic
CC       amino acids. Heterodimer SLC3A2/SLC7A11 functions as an antiporter by
CC       mediating the exchange of extracellular anionic L-cystine and
CC       intracellular L-glutamate across the cellular plasma membrane (By
CC       similarity). SLC3A2/SLC7A10 translocates small neutral L- and D-amino
CC       acids across the plasma membrane (By similarity). SLC3A2/SLC75 or
CC       SLC3A2/SLC7A8 translocates neutral amino acids with broad specificity,
CC       thyroid hormones and L-DOPA. SLC3A2 is essential for plasma membrane
CC       localization, stability, and the transport activity of SLC7A5 and
CC       SLC7A8. When associated with LAPTM4B, the heterodimer SLC7A5 is
CC       recruited to lysosomes to promote leucine uptake into these organelles,
CC       and thereby mediates mTORC1 activation. Modulates integrin-related
CC       signaling and is essential for integrin-dependent cell spreading,
CC       migration and tumor progression (By similarity).
CC       {ECO:0000250|UniProtKB:P08195, ECO:0000250|UniProtKB:P63115,
CC       ECO:0000269|PubMed:10049700, ECO:0000269|PubMed:10391916,
CC       ECO:0000269|PubMed:12614332, ECO:0000269|PubMed:15980244,
CC       ECO:0000269|PubMed:23426681, ECO:0000269|PubMed:9480885,
CC       ECO:0000269|PubMed:9726963}.
CC   -!- SUBUNIT: Disulfide-linked heterodimer with a non-glycosylated light
CC       chain (SLC7A5, SLC7A6, SLC7A7, SLC7A8, SLC7A10 or SLC7A11)
CC       (PubMed:10049700, PubMed:10391916, PubMed:9480885, PubMed:9726963).
CC       Interacts with TLCD3A/CT120 and ICAM1. Constitutively and specifically
CC       associates with beta-1 integrins (alpha-2/beta-1, alpha-3/beta-1,
CC       alpha-5/beta-1 and alpha-6/beta-1), but minimally with alpha-4/beta-1.
CC       Interacts with LAPTM4B; recruits SLC3A2 and SLC7A5 to lysosomes to
CC       promote leucine uptake into these organelles and is required for mTORC1
CC       activation (By similarity). {ECO:0000250|UniProtKB:P08195,
CC       ECO:0000269|PubMed:10049700, ECO:0000269|PubMed:10391916,
CC       ECO:0000269|PubMed:9726963, ECO:0000305|PubMed:9480885}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000250|UniProtKB:P08195}. Cell membrane
CC       {ECO:0000269|PubMed:10391916, ECO:0000269|PubMed:11095508,
CC       ECO:0000269|PubMed:9480885}; Single-pass type II membrane protein
CC       {ECO:0000250|UniProtKB:P08195}. Cell junction
CC       {ECO:0000250|UniProtKB:P10852}. Lysosome membrane
CC       {ECO:0000250|UniProtKB:P08195}. Melanosome
CC       {ECO:0000250|UniProtKB:P08195}. Basolateral cell membrane
CC       {ECO:0000250|UniProtKB:P10852}. Note=Localized at the plasma membrane
CC       when associated with SLC7A5 or SLC7A8. Localized to the apical membrane
CC       of placental syncytiotrophoblastic cells. Recruited to lysosomes by
CC       LAPTM4B (By similarity). Located selectively at cell-cell adhesion
CC       sites (By similarity). Colocalized with SLC7A8/LAT2 at the basolateral
CC       membrane of kidney proximal tubules and small intestine epithelia.
CC       Expressed in both luminal and abluminal membranes of brain capillary
CC       endothelial cells. {ECO:0000250|UniProtKB:P08195,
CC       ECO:0000250|UniProtKB:P10852, ECO:0000269|PubMed:11095508}.
CC   -!- TISSUE SPECIFICITY: In brain expressed on capillary endothelia in
CC       cerebral cortex (at protein level) (PubMed:11095508). Highest
CC       expression in kidney, jejunum, ileum, colon, placenta, testis and
CC       spleen. Lower levels found in liver, lung and brain with weakest
CC       expression in heart. Expressed in retina, inner blood-retinal barrier
CC       of retina, retinal vascular endothelial cells. Also expressed in C6
CC       glioma cells and in the retinal capillary endothelial cell line TR-
CC       iBRB2. {ECO:0000269|PubMed:10391916, ECO:0000269|PubMed:11095508,
CC       ECO:0000269|PubMed:15980244}.
CC   -!- INDUCTION: Expression induced in normal hepatic cells in the presence
CC       of actinomycin-D. {ECO:0000269|PubMed:15120633}.
CC   -!- PTM: Phosphorylation on Ser-300 and on Ser-421 by ecto-protein kinases
CC       favors heterotypic cell-cell interactions.
CC       {ECO:0000250|UniProtKB:P08195}.
CC   -!- PTM: N-glycosylated; N-glycosylation is crucial for trafficking and
CC       stability of SLC3A2 to the plasma membrane.
CC       {ECO:0000250|UniProtKB:P08195}.
CC   -!- SIMILARITY: Belongs to the SLC3A transporter family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U59324; AAC53560.1; -; mRNA.
DR   EMBL; AB015433; BAA33036.1; -; mRNA.
DR   EMBL; BC061989; AAH61989.1; -; mRNA.
DR   RefSeq; NP_001258018.1; NM_001271089.2.
DR   AlphaFoldDB; Q794F9; -.
DR   SMR; Q794F9; -.
DR   BioGRID; 248392; 3.
DR   IntAct; Q794F9; 2.
DR   MINT; Q794F9; -.
DR   STRING; 10116.ENSRNOP00000025196; -.
DR   CAZy; GH13; Glycoside Hydrolase Family 13.
DR   CarbonylDB; Q794F9; -.
DR   GlyCosmos; Q794F9; 8 sites, 8 glycans.
DR   GlyGen; Q794F9; 8 sites, 12 N-linked glycans (3 sites).
DR   iPTMnet; Q794F9; -.
DR   PhosphoSitePlus; Q794F9; -.
DR   SwissPalm; Q794F9; -.
DR   jPOST; Q794F9; -.
DR   PaxDb; 10116-ENSRNOP00000025196; -.
DR   GeneID; 50567; -.
DR   KEGG; rno:50567; -.
DR   UCSC; RGD:3073; rat.
DR   AGR; RGD:3073; -.
DR   CTD; 6520; -.
DR   RGD; 3073; Slc3a2.
DR   eggNOG; KOG0471; Eukaryota.
DR   HOGENOM; CLU_006462_9_0_1; -.
DR   InParanoid; Q794F9; -.
DR   OrthoDB; 4266085at2759; -.
DR   PhylomeDB; Q794F9; -.
DR   TreeFam; TF314498; -.
DR   Reactome; R-RNO-210991; Basigin interactions.
DR   Reactome; R-RNO-352230; Amino acid transport across the plasma membrane.
DR   Reactome; R-RNO-71240; Tryptophan catabolism.
DR   SABIO-RK; Q794F9; -.
DR   PRO; PR:Q794F9; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:1990184; C:amino acid transport complex; ISO:RGD.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0044225; C:apical pole of neuron; ISO:RGD.
DR   GO; GO:0009925; C:basal plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IC:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0015173; F:aromatic amino acid transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0003725; F:double-stranded RNA binding; ISO:RGD.
DR   GO; GO:0140272; F:exogenous protein binding; ISO:RGD.
DR   GO; GO:0015180; F:L-alanine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015190; F:L-leucine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0005294; F:neutral L-amino acid secondary active transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015175; F:neutral L-amino acid transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IEP:RGD.
DR   GO; GO:0015818; P:isoleucine transport; ISO:RGD.
DR   GO; GO:1904273; P:L-alanine import across plasma membrane; ISO:RGD.
DR   GO; GO:1902024; P:L-histidine transport; IDA:UniProtKB.
DR   GO; GO:1903801; P:L-leucine import across plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015820; P:L-leucine transport; IDA:UniProtKB.
DR   GO; GO:0015821; P:methionine transport; ISO:RGD.
DR   GO; GO:0015804; P:neutral amino acid transport; IMP:RGD.
DR   GO; GO:0015823; P:phenylalanine transport; IDA:UniProtKB.
DR   GO; GO:0015824; P:proline transport; ISO:RGD.
DR   GO; GO:0043330; P:response to exogenous dsRNA; ISO:RGD.
DR   GO; GO:0014850; P:response to muscle activity; IEP:RGD.
DR   GO; GO:0046718; P:symbiont entry into host cell; ISO:RGD.
DR   GO; GO:0070327; P:thyroid hormone transport; ISO:RGD.
DR   GO; GO:0015827; P:tryptophan transport; IDA:UniProtKB.
DR   GO; GO:0015828; P:tyrosine transport; ISO:RGD.
DR   GO; GO:0015829; P:valine transport; ISO:RGD.
DR   Gene3D; 3.20.20.80; Glycosidases; 1.
DR   Gene3D; 2.60.40.1180; Golgi alpha-mannosidase II; 1.
DR   InterPro; IPR006047; Glyco_hydro_13_cat_dom.
DR   InterPro; IPR013780; Glyco_hydro_b.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR042280; SLC3A2.
DR   InterPro; IPR031984; SLC3A2_N.
DR   PANTHER; PTHR46673; 4F2 CELL-SURFACE ANTIGEN HEAVY CHAIN; 1.
DR   PANTHER; PTHR46673:SF1; 4F2 CELL-SURFACE ANTIGEN HEAVY CHAIN; 1.
DR   Pfam; PF00128; Alpha-amylase; 1.
DR   Pfam; PF16028; SLC3A2_N; 1.
DR   SMART; SM00642; Aamy; 1.
DR   SUPFAM; SSF51445; (Trans)glycosidases; 1.
DR   SUPFAM; SSF51011; Glycosyl hydrolase domain; 1.
PE   1: Evidence at protein level;
KW   Amino-acid transport; Cell junction; Cell membrane; Disulfide bond;
KW   Glycoprotein; Isopeptide bond; Lysosome; Membrane; Phosphoprotein;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix;
KW   Transport; Ubl conjugation.
FT   CHAIN           1..527
FT                   /note="Amino acid transporter heavy chain SLC3A2"
FT                   /id="PRO_0000252236"
FT   TOPO_DOM        1..75
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        76..98
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        99..527
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..18
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         5
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08195"
FT   MOD_RES         300
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08195"
FT   MOD_RES         421
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08195"
FT   CARBOHYD        166
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        249
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        259
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P08195"
FT   CARBOHYD        263
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        318
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P08195"
FT   CARBOHYD        386
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        400
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P08195"
FT   CARBOHYD        510
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        103
FT                   /note="Interchain (with C-164 in SLC7A5; C-158 in SLC7A11
FT                   and C-153 in SLC7A8)"
FT                   /evidence="ECO:0000250|UniProtKB:P08195"
FT   CROSSLNK        42
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P08195"
FT   CROSSLNK        59
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P08195"
SQ   SEQUENCE   527 AA;  58072 MW;  CBA92D830893672B CRC64;
     MSQDTEVDMK DVELNELEPE KQPMNAADGA AAGEKNGLVK IKVAEDEAEA GVKFTGLSKE
     ELLKVAGSPG WVRTRWALLL LFWLGWLGML AGAVVIIVRA PRCRELPVQR WWHKGALYRI
     GDLQAFVGPE ARGIAGLKNH LEYLSTLKVK GLVLGPIHKN QKDEVNETDL KQIDPDLGSQ
     EDFKDLLQSA KKKSIHIILD LTPNYKGQNA WFLPPQADIV ATKMKEALSS WLQDGVDGFQ
     VRDVGKLANA SLYLAEWQNI TKNFSEDRLL IAGTASSDLQ QIVNILESTS DLLLTSSYLS
     QPVFTGEHAE LLVIKYLNAT GSRWCSWSVS QAGLLTSFIP AQFLRLYQLL LFTLPGTPVF
     SYGDELGLQA VALPGQPMEA PFMLWNESSN SQTSSPVSLN MTVKGQNEDP GSLLTQFRRL
     SDLRGKERSL LHGDFDALSS SSGLFSYVRH WDQNERYLVV LNFQDVGLSA RVGASNLPAG
     ISLPASANLL LSTDSTRLSR EEGTSLSLEN LSLNPYEGLL LQFPFVA
//
